Lanean...
RECIST 1.1 and lesion selection: How to deal with ambiguity at baseline?
Response Evaluation Criteria In Solid Tumors (RECIST) is still the predominant criteria base for assessing tumor burden in oncology clinical trials. Despite several improvements that followed its first publication, RECIST continues to allow readers a lot of freedom in their evaluations. Notably in t...
Gorde:
| Argitaratua izan da: | Insights Imaging |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer International Publishing
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7973344/ https://ncbi.nlm.nih.gov/pubmed/33738548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13244-021-00976-w |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|